Overview
Current Appointments & Affiliations
Professor of Medicine
·
2018 - Present
Medicine, Medical Oncology,
Medicine
Member of the Duke Cancer Institute
·
2004 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Examining the Interrelationships of Lymphedema with Pain, Physical Function, and Demographic and Medical Variables in Women with Breast Cancer and Pain.
Journal Article Clin Breast Cancer · July 9, 2025 PURPOSE: To examine the relationship of lymphedema with pain, physical function, and demographic and medical variables in women with breast cancer and pain. METHODS: Secondary analysis of baseline data from a study of women with breast cancer and pain. Sel ... Full text Link to item CiteAdjuvant Radiation vs Endocrine Therapy After Lumpectomy for Early-Stage Breast Cancer in Older Women: Analysis of Real-World Survival Outcomes.
Journal Article Ann Surg Oncol · June 6, 2025 BACKGROUND: We examined whether adjuvant radiation therapy (RT) monotherapy offers comparable overall survival (OS) to adjuvant endocrine therapy (ET) monotherapy following lumpectomy in women aged ≥ 65 years with favorable early stage breast cancer. PATIE ... Full text Link to item CiteDisparities in treatment delays among metastatic breast cancer patients: insights from nationwide electronic health records, 2011-2022.
Journal Article Breast Cancer Res Treat · April 2025 PURPOSE: While previous research has highlighted treatment delay inequities in early-stage breast cancer and identified potential contributing factors, there is limited research on disparities in treatment delays for metastatic breast cancer (MBC). This st ... Full text Link to item CiteRecent Grants
A randomized phase II trial of adjuvant trastuzumab emtansine (T-DM1) followed by subcutaneous trastuzumab versus paclitaxel in combination with subcutaneous trastuzumab for Stage I HER2-positive breast cancer (ATEMPT 2.0)
Clinical TrialPrincipal Investigator · Awarded by Dana-Farber Cancer Institute · 2023 - 2028Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence caused by Aromatase Inhibitor-Associated Arthralgia in Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial
ResearchCo Investigator · Awarded by Northwestern University · 2022 - 2027Evaluating a Patient Navigation Program to Improve Therapy Management for HER2+ Metastatic Breast Cancer Patients Treated with Tucatinib
ResearchCo Investigator · Awarded by Pfizer, Inc. · 2025 - 2026View All Grants
Education, Training & Certifications
Wake Forest University ·
2000
M.S.
Wake Forest University ·
1989
M.D.